butoxamine has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gamelli, RL; Hasan, S; Mosier, MJ; Muthumalaiappan, K; Szilagyi, A | 1 |
Bratasz, A; Guan, Z; Huang, K; Mandrekar-Colucci, S; Nash, MS; Popovich, PG; Powell, ND; Rabchevsky, AG; Reader, B; Shawler, T; Sheridan, JF; Weil, Z; Wells, J; Whitacre, CC; Zhang, Y | 1 |
Furuya, H; Hirai, K; Inoue, S; Kato, H; Kawaguchi, M | 1 |
Alzate, WD; Calderon, GM; Cook, KM; Kotamarti, S; Livingston, DH; Mohr, AM; Pasupuleti, LV; Sifri, ZC | 1 |
4 other study(ies) available for butoxamine and Disease Models, Animal
Article | Year |
---|---|
Discrete β-adrenergic mechanisms regulate early and late erythropoiesis in erythropoietin-resistant anemia.
Topics: Adrenergic Antagonists; Anemia; Animals; Burns; Butoxamine; Disease Models, Animal; Erythropoiesis; Male; Mice; Nadolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2017 |
Autonomic dysreflexia causes chronic immune suppression after spinal cord injury.
Topics: Adrenergic beta-2 Receptor Antagonists; Animals; Antigens, CD; Autonomic Dysreflexia; Blood Pressure; Butoxamine; Colon; Corticosterone; Disease Models, Animal; Epinephrine; Female; Hormone Antagonists; Humans; Immune System Diseases; Immunosuppression Therapy; Mice; Mifepristone; Norepinephrine; Ovalbumin; Physical Stimulation; Spinal Cord Injuries; T-Lymphocytes; Telemetry | 2013 |
The effects of beta-adrenoceptor antagonists on proinflammatory cytokine concentrations after subarachnoid hemorrhage in rats.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Butoxamine; Disease Models, Animal; Inflammation Mediators; Interleukin-6; Male; Metoprolol; Neuroprotective Agents; Propranolol; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage; Time Factors; Tumor Necrosis Factor-alpha | 2009 |
Does selective beta-1 blockade provide bone marrow protection after trauma/hemorrhagic shock?
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Bone Marrow; Butoxamine; Contusions; Disease Models, Animal; Hematopoietic Stem Cells; Lung Injury; Male; Propanolamines; Protective Agents; Rats; Rats, Sprague-Dawley; Shock, Hemorrhagic | 2012 |